ZA991749B - Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy. - Google Patents

Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.

Info

Publication number
ZA991749B
ZA991749B ZA9901749A ZA991749A ZA991749B ZA 991749 B ZA991749 B ZA 991749B ZA 9901749 A ZA9901749 A ZA 9901749A ZA 991749 A ZA991749 A ZA 991749A ZA 991749 B ZA991749 B ZA 991749B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
therapy
pharmaceutical composition
diseases associated
ocular fundus
Prior art date
Application number
ZA9901749A
Other languages
English (en)
Inventor
Mitsuyoshi Azuma
Yukuo Yoshida
Yuji Sakamoto
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of ZA991749B publication Critical patent/ZA991749B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA9901749A 1998-03-05 1999-03-04 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy. ZA991749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5362498 1998-03-05

Publications (1)

Publication Number Publication Date
ZA991749B true ZA991749B (en) 1999-09-16

Family

ID=12948075

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901749A ZA991749B (en) 1998-03-05 1999-03-04 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.

Country Status (17)

Country Link
US (1) US6423691B1 (de)
EP (2) EP1504760B1 (de)
JP (1) JP4422894B2 (de)
KR (1) KR20010041605A (de)
CN (1) CN1298304A (de)
AR (1) AR018576A1 (de)
AT (2) ATE296635T1 (de)
AU (1) AU2745599A (de)
BR (1) BR9908566A (de)
CA (1) CA2322854A1 (de)
DE (2) DE69925578T2 (de)
HU (1) HUP0101733A3 (de)
ID (1) ID27083A (de)
NO (1) NO20004405L (de)
PL (1) PL343412A1 (de)
WO (1) WO1999044624A2 (de)
ZA (1) ZA991749B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002034252A1 (ja) * 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
JP4549851B2 (ja) * 2002-07-22 2010-09-22 千寿製薬株式会社 新規α−ケトアミド誘導体およびその用途
CN1330992C (zh) 2002-09-19 2007-08-08 皇家飞利浦电子股份有限公司 电润湿光学开关
AU2003292838A1 (en) * 2002-12-27 2004-07-29 Kirin Beer Kabushiki Kaisha Therapeutic agent for wet age-related macular degeneration
DK2435024T3 (en) 2009-05-29 2016-10-24 Pearl Therapeutics Inc Compositions for the respiratory delivery of active agents and related methods and systems
WO2011105070A1 (ja) 2010-02-25 2011-09-01 パナソニック株式会社 需給制御装置、需給制御方法、およびプログラム
EP2593089B1 (de) 2010-07-14 2018-04-04 Senju Pharmaceutical Co., Ltd. Feste dispersion eines alfa-ketoamid-derivats
RU2452436C1 (ru) * 2011-01-31 2012-06-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения атрофии зрительного нерва сосудистого генеза
ES2859023T3 (es) * 2014-02-21 2021-09-30 Sumitomo Dainippon Pharma Co Ltd Agente para el tratamiento de enfermedades oculares, método de detección por ello y método para predecir la respuesta al rechazo asociado con el trasplante de células epiteliales de pigmento retinal
EP3347034B1 (de) 2015-09-11 2024-05-29 The Schepens Eye Research Institute, Inc. Eine hepatozyten-wachstumsfaktor-rezeptor (hgfr)-bindende zusammensetzung zur verwendung in einem verfahren zur behandlung von hornhauttrübung oder -vernarbung
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
JP2848232B2 (ja) 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
JP3599287B2 (ja) 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
EP0731107A1 (de) * 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Herstellung von Aldehyd-Derivaten
ES2193615T3 (es) * 1995-10-25 2003-11-01 Senju Pharma Co .nhibidor de la angiogenesis.
ES2293651T3 (es) 1995-11-28 2008-03-16 Cephalon, Inc. Inhibidores de cisteina y serina proteasas derivados de aminoacidos d.
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung

Also Published As

Publication number Publication date
PL343412A1 (en) 2001-08-13
HUP0101733A3 (en) 2001-12-28
DE69925578T2 (de) 2006-04-27
EP1504760A1 (de) 2005-02-09
DE69939075D1 (de) 2008-08-21
AU2745599A (en) 1999-09-20
ATE296635T1 (de) 2005-06-15
AR018576A1 (es) 2001-11-28
KR20010041605A (ko) 2001-05-25
CN1298304A (zh) 2001-06-06
CA2322854A1 (en) 1999-09-10
DE69925578D1 (de) 2005-07-07
WO1999044624A3 (en) 1999-10-21
NO20004405D0 (no) 2000-09-04
ATE400277T1 (de) 2008-07-15
BR9908566A (pt) 2000-11-21
US6423691B1 (en) 2002-07-23
EP1058553A2 (de) 2000-12-13
ID27083A (id) 2001-02-22
WO1999044624A2 (en) 1999-09-10
JP2002505297A (ja) 2002-02-19
EP1504760B1 (de) 2008-07-09
HUP0101733A2 (hu) 2001-11-28
EP1058553B1 (de) 2005-06-01
JP4422894B2 (ja) 2010-02-24
NO20004405L (no) 2000-11-03

Similar Documents

Publication Publication Date Title
HK1037861A1 (en) Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
AU2003272536A8 (en) Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
AU3886199A (en) Medical device for dissolution of tissue within the human body
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
IL178072A0 (en) Use of monoesters of probucol or a pharmaceutically acceptable salt thereof for preparing medicaments for the treatment of cardiovascular disease
IL127943A0 (en) Pharmaceutical and cosmetic composition for the treatment of skin disorders
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
HK1061209A1 (en) Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU3401093A (en) Therapeutic agent for threatened abortion
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
HUP0103017A3 (en) Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
EP0687687A3 (de) Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
BR9916963A (pt) Bupropiona para tratamento de doenças virais
GB9908059D0 (en) Diagnosis and treatment of diseases
NO20001895D0 (no) Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
HUP0203309A3 (en) Therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics for treatment or prevention of phychotic disorders and pharmaceutical compositions containing them
AUPQ423199A0 (en) Compositions for the treatment of infectious and/or skin diseases